PNC Financial Services Group
EWTX icon

PNC Financial Services Group’s Edgewise Therapeutics EWTX Stock Holding History

PNC Financial Services Group’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.15K Buy
176
+4
+2% +$138 ﹤0.01% 4245
2026
Q1 		$5.42K Buy
172
+97
+129% +$2.8K ﹤0.01% 4233
2025
Q4 		$1.86K Buy
75
+8
+12% +$161 ﹤0.01% 4546
2025
Q3 		$1.09K Buy
67
+18
+37% +$255 ﹤0.01% 4655
2025
Q2 		$642 Buy
+49
New +$707 ﹤0.01% 4641
2024
Q2 		– Sell
-4
Closed -$73 – 4795
2024
Q1 		$73 Sell
4
-6
-60% -$95 ﹤0.01% 4652
2023
Q4 		$109 Buy
+10
New +$70 ﹤0.01% 4515
2023
Q2 		– Sell
-202
Closed -$1.35K – 4773
2023
Q1 		$1.35K Hold
202
– – ﹤0.01% 4385
2022
Q4 		$1.81K Hold
202
– – ﹤0.01% 4289
2022
Q3 		$2K Sell
202
-128
-39% -$1.29K ﹤0.01% 4170
2022
Q2 		$2K Buy
+330
New +$2.49K ﹤0.01% 4192

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group's EWTX Position: Q2 2026 in Review

PNC Financial Services Group increased its Edgewise Therapeutics (EWTX) stake by 2.3% in Q2 2026, buying an estimated $138 and bringing the position to 176 shares worth $7.15K. The position accounts for ﹤0.01% of the portfolio, ranked #4245.

PNC Financial Services Group first reported a position in EWTX in Q2 2022 and has held it in 11 quarters since. 225 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • PNC Financial Services Group held 176 shares of Edgewise Therapeutics worth $7.15K as of Q2 2026.
  • PNC Financial Services Group bought 4 Edgewise Therapeutics shares in Q2 2026, an estimated $138.
  • Edgewise Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4245 holding.
  • PNC Financial Services Group first reported a position in Edgewise Therapeutics in Q2 2022 and has held it in 11 quarters since.
  • 225 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.